Page last updated: 2024-08-22

angiotensin ii and Shock

angiotensin ii has been researched along with Shock in 129 studies

Research

Studies (129)

Timeframe	Studies, this research(%)	All Research%
pre-1990	62 (48.06)	18.7374
1990's	5 (3.88)	18.2507
2000's	4 (3.10)	29.6817
2010's	30 (23.26)	24.3611
2020's	28 (21.71)	2.80

Authors

Authors	Studies
Berry, TP; Haines, MM; Kozinn, J; Mohamed, A; Thomas, EL; Welge, JA; Zhurav, L	1
Chen, A; Wong, A	1
Ali, S; Awad, SS; Bird, S; Chand, M; Cornwell, LD; Jimenez, E; Schutz, A; Tran, TL	1
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE	1
Bansal, M; Belford, PM; Khanna, AK; Mehta, A; Vallabhajosyula, S; Wieruszewski, PM; Zhao, DX	1
Bellomo, R; Boldt, DW; Busse, LW; Chow, JH; Deane, AM; Greenfeld, CR; Ham, KR; Hodges, T; Khanna, AK; Kroll, S; Ostermann, M; Wieruszewski, PM; Wunderink, RG; Zarbock, A	1
Garcia, B; Legrand, M	1
Engoren, MC; Mentz, GB; Smith, LM	1
Alkazemi, A; Cocchi, MN; Eche, IM; Petri, CR; Sarge, T; Wong, A	1
Russell, JA	1
Allen, JM; Gilbert, BW	1
Albertson, TE; Bellomo, R; Busse, LW; Chawla, LS; Deane, AM; English, SW; Handisides, DR; Khanna, AK; McCurdy, MT; Ostermann, M; Szerlip, H; Tidmarsh, GF; Wunderink, RG; Young, PJ	1
Jansen, G; Morelli, A; Rehberg, S	1
Chow, JH; McCurdy, MT; Wallis, MC; Winters, ME	1
Albertson, TE; Busse, LW; Lee, CH; Nicholson, G; Nordyke, RJ; Zeng, F	1
Chow, JH; Mazzeffi, MA; McCurdy, MT	2
Bellomo, R; Beretta, L; Landoni, G; Morselli, F; Serpa Neto, A; Zangrillo, A	1
Lumlertgul, N; Ostermann, M	1
Casey, JD; Semler, MW	1
Bobeck, KA; Brown, TE; Clark, PA; Holtzclaw, AW	1
Boyd, JH; Gordon, AC; Kissoon, N; Russell, JA; Walley, KR; Williams, MD	1
Bredeck, JF; Cutler, NS; Khanna, AK; Lata, AL; Rasmussen, BM	1
Barreto, EF; Brown, DR; Butler, SO; Clark, AM; Cooper, CJ; Davison, DL; Gajic, O; Gunnerson, KJ; Kashani, KB; Mara, KC; Tendler, R; Wieruszewski, PM; Wittwer, ED	1
Cutler, NS; Khanna, AK	1
Al Husami, W; Alkhatib Tamimi, F; Ganatra, S; Liu, Y; Ofosu-Barko, K; Resnic, F; Shah, SP	1
Chow, JH; Guo, Y; Hecht, J; Kethireddy, S; Mazzeffi, MA; McCurdy, MT; Newsome, AS; Smith, SE	1
Patel, GP; Running, K; Sullivan, CL; Trudo, W; Weinberg, D	1
Alam, A; Colbert, GB; Gill, J; Hughes, GJ; Mooney, JL; Ragula, N; Salem, M; Sovic, W	1
Albertson, TE; Altaweel, L; Bellomo, R; Boldt, DW; Busse, LW; Chawla, LS; Chock, S; Deane, AM; English, SW; Favory, R; Gong, MN; Ham, K; Hästbacka, J; Jensen, J; Khanna, A; Krell, K; Kroll, S; Mackey, C; McCurdy, MT; Murugan, R; Ostermann, M; Panwar, R; Szerlip, H; Thompson, BT; Tidmarsh, GF; Tumlin, J; Venkatesh, B; Wang, XS; Wunderink, RG; Young, PJ	1
Fernández-Ruiz, I	1
Dellinger, RP; Trzeciak, S	1
Agosta, S; Antonucci, E; Sakr, Y	1
Bellomo, R; Khanna, A; Ostermann, M	1
Antonucci, E; Gleeson, PJ	1
Ali, O; Busse, LW; Chen, H; Hall, A; McCurdy, MT; Ostermann, M	1
Ammar, H; Fouda, R	1
Haeberle, HA; Rosenberger, P	1
Dünser, MW; Meier, J	1
Hertig, A; Jamme, M; Rafat, C	1
Janssens, U	1
Belletti, A; Landoni, G	1
Bellomo, R; Bihorac, A; Busse, LW; Chawla, LS; Deane, AM; Finkel, KW; Forni, LG; Ham, KR; Jensen, J; Kashani, K; Kroll, S; Lynch, SJ; Murugan, R; Ostermann, M; Prowle, JR; Szerlip, HM; Tidmarsh, GF; Tumlin, JA; Zarbock, A	1
Bissell, BD; Browder, K; Flannery, AH; McKenzie, M	1
Buchtele, N; Jilma, B; Schwameis, M	1
Bauer, SR; Lam, SW; Sacha, GL	1
Boldt, DW; Gunnerson, K; Harper, MD; Lim, GW; Ostermann, M	1
Abril, MK; Busse, LW; Handisides, D; Khanna, AK; Kroll, S; McNamara, C	1
Benken, S; Cucci, M; Fernandez, E; Kane, S; Rodriguez, R	1
Rascona, DA; Roy-Shapira, A	1
Bellomo, R; Chawla, LS; Kroll, S; Tidmarsh, GF	1
Busse, LW; Khanna, AK; Wakefield, BJ	1
Khan, YA; McCredie, VA; Morales-Castro, D; Spring, J	1
Antonucci, E; Taccone, FS	1
Kleinsasser, A; Knotzer, H; Poidinger, B	1
Johnson, PA; Thomovsky, E	1
Alotaibi, Z; Brasha-Mitchell, E; Busse, LW; Chawla, LS	1
Antunes-Rodrigues, J; Araujo, IG; Elias, LL; Mecawi, AS; Reis, LC; Vilhena-Franco, T	1
DEL GRECO, F; JOHNSON, DC	1
SPINK, WW; VICK, J	1
FINSTAD, J; MELBY, JC; SPINK, WW; VICK, JA	1
WEDEEN, R; ZUCKER, G	1
BEANLANDS, DS; GUNTON, RW	1
LARRAZASMITH, R; PORRASRAMIREZ, G; VAZQUEZNAVARRO, E	1
BRUNNER, H; IMHOF, P; JACONO, A; QUITT, J; STEINMANN, B	1
Arrigo, AP; Chen, Y; Currie, RW	1
Dünser, MW; Friesenecker, BE; Hasibeder, WR; Knotzer, H; Mayr, AJ; Pajk, W; Schwarz, S; Ulmer, H; Wenzel, V	1
Mouri, T; Murakami, O; Yoshinaga, K	1
Altura, BM	1
Börner, H; Klinkmann, H	1
Miyazaki, M	1
Bulkley, GB; Reilly, PM	1
Renaud, LP	1
Aneman, A; Eisenhofer, G; Fändriks, L; Friberg, P; Holm, M; Pettersson, A; von Bothmer, C	1
Huang, WC; Tsai, LM	1
Cassat, C; Desachy, A; François, B; Gastinne, H; Normand, S; Vignon, P	1
Diaz, J; Mets, B; Pantuck, CB; Soo, E	1
Ledingham, IM; Routh, GS	1
Mitch, WE; Walker, WG	1
Brown, CB	1
Helmchen, U; Thurau, K	1
Miyazaki, M; Yukioka, N	1
Kovách, AG; Sándor, P	1
Sander Jensen, K	1
Szilagyi, JE	1
Astrup, A; Bie, P; Christensen, NJ; Giese, J; Rørsgaard, S; Sander Jensen, K; Schwartz, TW; Secher, NH; Warberg, J	1
Badder, EM; Duarte, B; Hamaji, M; Harrison, TS; Seaton, JF	1
Cohn, JN; Luria, MH	1
Magyar, S; Szabó, G	1
Briguglio, FS; Perroni, G	1
Botticelli, JT; Lange, RL; Tsagaris, TJ	1
Faerchtein, I; Kastansky, I; Maciel, FS; Roque, AF	1
Gemperle, M; Megevand, R; Moret, PR	1
Bloch, JH; Dietzman, RH; Lillehei, RC; Lyons, GW	1
Beck, R; Bucklitsch, W; Faulhaber, H; Gawellek, F; Grünewald, G	1
Altura, BM; Hershey, SG	2
Malhotra, RP; Singh, S	2
Evreux, JC; Faucon, G; Frederich, A; Kofman, J; Lavarenne, J	1
Adamska-Dyniewska, H	1
Robb, HJ	1
Brand, ED; Lefer, AM	1
Enderlin, F; Gigon, JP; Wolff, G	2
Collard, M; Evreux, JC; Faucon, G; Lavarenne, J; Perrot, E	1
Kassel, H	1
Markiewicz, M	2
Litton, A	1
Rex, H; Schulze, E	1
Halmagyi, DF; Neering, IR; Pullin, J; Varga, D	1
Chlup, J; Klener, P	1
Lewis, CM; Weil, MH	1
Schröder, R	1
Chiri, A; Momo, D	1
Samele Acquaviva, E	1
Cohn, JN; Tristani, FE	1
Bazaugour, R; Evreux, JC; Faucon, G; Perrot, E	1
Wardle, EN	1
Farrell, P; Fitzgerald, O; Fitzgerald, P; Geoghegan, C; Heffernan, A; McGeeney, K	1
Habermann, E	1
Hartel, W; Lenz, J; Linder, MM; Muschaweck, R	1
Gross, F	1
Ahlquist, RP	1
Reubi, FC	1
Reubi, F; Tuckman, J; Vorburger, C	1
Reichmann, W	1
Corbascio, AN; Smith, NT	1

Reviews

29 review(s) available for angiotensin ii and Shock

Article	Year
The Role of Angiotensin II in Poisoning-Induced Shock-a Review. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2022, Volume: 18, Issue:2 Topics: Angiotensin II; Drug Overdose; Epinephrine; Humans; Norepinephrine; Shock; Vasoconstrictor Agents	2022
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock. Expert review of clinical pharmacology, 2022, Volume: 15, Issue:8 Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins	2022
Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review. The American journal of emergency medicine, 2023, Volume: 66 Topics: Angiotensin II; Arterial Pressure; Humans; Norepinephrine; Peptide Hormones; Shock; Shock, Cardiogenic; Vasoconstrictor Agents	2023
Vasopressor therapy in critically ill patients with shock. Intensive care medicine, 2019, Volume: 45, Issue:11 Topics: Angiotensin II; Critical Illness; Dopamine; Epinephrine; Humans; Methylene Blue; Norepinephrine; Phenylephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins	2019
Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock. Clinical therapeutics, 2019, Volume: 41, Issue:12 Topics: Angiotensin II; Critical Care; Humans; Shock; Vasoconstrictor Agents	2019
Angiotensin II for the emergency physician. Emergency medicine journal : EMJ, 2020, Volume: 37, Issue:11 Topics: Angiotensin II; Critical Care; Emergency Service, Hospital; Humans; Hypotension; Shock; Vasoconstrictor Agents	2020
Roles of angiotensin II as vasopressor in vasodilatory shock. Future cardiology, 2020, Volume: 16, Issue:6 Topics: Angiotensin II; Blood Pressure; Humans; Randomized Controlled Trials as Topic; Shock; Vasoconstrictor Agents; Vasodilation	2020
Angiotensin II: A Review of Current Literature. Journal of cardiothoracic and vascular anesthesia, 2022, Volume: 36, Issue:4 Topics: Angiotensin II; Humans; Shock; United States; Vasoplegia	2022
Pharmacotherapy: Angiotensin II - a new tool in vasodilatory shock. Nature reviews. Cardiology, 2017, Jun-14, Volume: 14, Issue:7 Topics: Angiotensin II; Blood Pressure; Humans; Shock; Vasoconstrictor Agents; Vasodilation	2017
The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature. Critical care (London, England), 2017, Dec-28, Volume: 21, Issue:1 Topics: Angiotensin II; Blood Pressure; Humans; Monitoring, Physiologic; Shock	2017
Angiotensin II increases blood pressure in patients with refractory vasodilatory shock. BMJ evidence-based medicine, 2018, Volume: 23, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Blood Pressure Determination; Hemodynamics; Humans; Shock; Shock, Septic; Vasoconstrictor Agents; Vasodilation	2018
A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock. The Annals of pharmacotherapy, 2018, Volume: 52, Issue:9 Topics: Angiotensin II; Animals; Humans; Shock; Treatment Outcome; Vasoconstrictor Agents	2018
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock. Pharmacotherapy, 2018, Volume: 38, Issue:8 Topics: Angiotensin II; Drug-Related Side Effects and Adverse Reactions; Humans; Shock; Vasoconstrictor Agents; Vasopressins	2018
Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin. Journal of intensive care medicine, 2020, Volume: 35, Issue:4 Topics: Adult; Angiotensin II; Arterial Pressure; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Shock; Treatment Outcome; Vasoconstrictor Agents; Vasopressins	2020
Angiotensin II in Vasodilatory Shock. Critical care clinics, 2019, Volume: 35, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Female; Humans; Male; Middle Aged; Shock; Treatment Outcome; Vasoconstrictor Agents; Vasodilation	2019
Pharmacologic Agents for the Treatment of Vasodilatory Shock. Current pharmaceutical design, 2019, Volume: 25, Issue:19 Topics: Angiotensin II; Catecholamines; Humans; Norepinephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasodilation; Vasopressins	2019
[Blood pressure regulation and shock]. Nihon rinsho. Japanese journal of clinical medicine, 1983, Volume: 41, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Endorphins; Hypertension; Nerve Tissue Proteins; Neurotensin; Rats; Rats, Inbred Strains; Shock; Substance P; Vasopressins	1983
Microcirculatory and vascular smooth muscle behavior in the Brattleboro rat: relationship to reticuloendothelial system function and resistance to shock and trauma. Annals of the New York Academy of Sciences, 1982, Volume: 394 Topics: Angiotensin II; Animals; Aorta; Arterioles; Blood Pressure; Catecholamines; Diabetes Insipidus; Female; Homeostasis; Male; Microcirculation; Mononuclear Phagocyte System; Muscle Contraction; Muscle, Smooth, Vascular; Oxytocin; Phagocytosis; Rats; Rats, Brattleboro; Rats, Inbred Strains; Rats, Mutant Strains; Shock; Vasopressins; Wounds and Injuries	1982
Pathogenesis of acute noninflammatory renal failure. Nephron, 1980, Volume: 25, Issue:6 Topics: Acute Kidney Injury; Angiotensin II; Animals; Humans; Kidney; Kidney Tubules; Nervous System Diseases; Prostaglandins; Regional Blood Flow; Renin; Shock	1980
[Clinical indices for reversible and irreversible shock and their thresholds]. Nihon rinsho. Japanese journal of clinical medicine, 1980, Volume: 38, Issue:4 Topics: Angiotensin II; Animals; Cardiac Output; Humans; Lung; Mononuclear Phagocyte System; Pancreas; Renin; Shock; Shock, Cardiogenic	1980
Vasoactive mediators and splanchnic perfusion. Critical care medicine, 1993, Volume: 21, Issue:2 Suppl Topics: Angiotensin II; Animals; Hemodynamics; Humans; Intestines; Ischemia; Shock; Splanchnic Circulation; Vasoconstriction	1993
[Shock kidney (author's transl)]. Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1978, Volume: 62 Topics: Acute Kidney Injury; Angiotensin II; Animals; Chlorides; Glomerular Filtration Rate; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Tubules; Potassium; Rats; Regional Blood Flow; Renin; Shock; Sodium	1978
Cerebral blood flow and brain function during hypotension and shock. Annual review of physiology, 1976, Volume: 38 Topics: Acetylcholine; Angiotensin II; Animals; Brain; Brain Stem; Cardiac Output; Cerebellum; Cerebral Cortex; Cerebrovascular Circulation; Diencephalon; Electroencephalography; Epinephrine; Evoked Potentials; Humans; Hypotension; Hypothalamus; Hypoxia; Norepinephrine; Reflex; Regional Blood Flow; Serotonin; Shock; Shock, Hemorrhagic; Sympathetic Nervous System; Synapses; Vasomotor System	1976
Heart and endocrine changes during central hypovolemia in man. Danish medical bulletin, 1991, Volume: 38, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Atropine; beta-Endorphin; Blood Pressure; Blood Volume; Endocrine Glands; Heart Rate; Humans; Myocardium; Pressoreceptors; Renin; Shock; Shock, Hemorrhagic; Vasopressins	1991
Endogenous opiates and the pathogenesis of hypertension. Clinical and experimental hypertension. Part A, Theory and practice, 1989, Volume: 11, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Endorphins; Hypertension; Hypertension, Renovascular; Models, Cardiovascular; Naloxone; Narcotics; Pain; Pressoreceptors; Shock	1989
[Vasopressor drugs in shock due to myocardial infarction]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1967, Oct-02, Volume: 22, Issue:45 Topics: Angiotensin II; Epinephrine; Humans; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vasoconstrictor Agents	1967
[Modern aspects of shock treatment]. Zeitschrift fur arztliche Fortbildung, 1968, Jul-15, Volume: 62, Issue:14 Topics: Adrenal Cortex Hormones; Analgesics; Angiotensin II; Animals; Anti-Bacterial Agents; Buffers; Cardiac Glycosides; Catecholamines; Diuretics; Electrolytes; Fibrinolytic Agents; Humans; Plasma Substitutes; Rabbits; Rats; Shock; Sympatholytics; Transfusion Reaction; Vasopressins	1968
[Mediators in shock processes: pathogenetic and therapeutic problems]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1971, Volume: 77 Topics: Acetylcholine; Adrenal Cortex Hormones; Anaphylaxis; Angiotensin II; Animals; Blood Vessels; Cell Membrane Permeability; Complement System Proteins; Dogs; Endotoxins; Haplorhini; Histamine; Humans; Kinins; Norepinephrine; Phospholipases; Rabbits; Serotonin; Shock; Shock, Hemorrhagic; Shock, Septic; Trypsin	1971
The use and misuse of pressor agents. Anesthesiology, 1970, Volume: 33, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anesthesia, Spinal; Angiotensin II; Blood Vessels; Dopamine; Ephedrine; Epinephrine; Felypressin; Glucagon; Heart; Humans; Isoproterenol; Mephentermine; Metaraminol; Methamphetamine; Methoxamine; Norepinephrine; Phenylephrine; Shock; Vasoconstrictor Agents	1970

Trials

7 trial(s) available for angiotensin ii and Shock

Article	Year
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Critical care (London, England), 2023, 05-05, Volume: 27, Issue:1 Topics: Angiotensin II; Humans; Hypotension; Norepinephrine; Prospective Studies; Shock; Vasoconstrictor Agents	2023
Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis. International journal of technology assessment in health care, 2020, Volume: 36, Issue:2 Topics: Adult; Aged; Angiotensin II; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Life Expectancy; Male; Middle Aged; Models, Econometric; Organ Dysfunction Scores; Quality-Adjusted Life Years; Severity of Illness Index; Shock; United States; Vasoconstrictor Agents	2020
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 08-03, Volume: 377, Issue:5 Topics: Aged; Angiotensin II; Blood Pressure; Catecholamines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension; Male; Middle Aged; Organ Dysfunction Scores; Shock; Vasoconstrictor Agents	2017
Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Critical care medicine, 2004, Volume: 32, Issue:6 Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Endocrine Glands; Endothelin-1; Female; Hemodynamics; Humans; Hydrocortisone; Infusions, Intravenous; Male; Norepinephrine; Prolactin; Prospective Studies; Renin; Shock	2004
[Use of hypertensin in the treatment of shock in myocardial infarct]. Hospital (Rio de Janeiro, Brazil), 1965, Volume: 68, Issue:3 Topics: Adult; Aged; Angiotensin II; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial Infarction; Shock	1965
Comparative study of angiotensin and nor-adrenaline in hypotensive states (shock). The Journal of the Association of Physicians of India, 1966, Volume: 14, Issue:11 Topics: Adolescent; Adult; Angiotensin II; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Norepinephrine; Shock	1966
[Pathogenesis of acute kidney failure in shock and renal circulation in man]. Journal d'urologie et de nephrologie, 1973, Volume: 79, Issue:12 Topics: Acute Kidney Injury; Angiotensin II; Catecholamines; Chromium Radioisotopes; Clinical Trials as Topic; Dye Dilution Technique; Edetic Acid; Hemodynamics; Humans; Indocyanine Green; Ischemia; Kidney; Kidney Glomerulus; Methods; Microscopy, Electron; Prostaglandins; Radioisotopes; Radionuclide Imaging; Regional Blood Flow; Renin; Shock; Sodium Isotopes; Xenon	1973

Other Studies

93 other study(ies) available for angiotensin ii and Shock

Article	Year
Angiotensin II in Patients With Shock on Mechanical Circulatory Support: A Single-Center Retrospective Case Series. Journal of cardiothoracic and vascular anesthesia, 2022, Volume: 36, Issue:8 Pt A Topics: Angiotensin II; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Shock; Shock, Cardiogenic	2022
Evaluation of the Addition of Angiotensin II in Patients With Shock After Cardiac Surgery at a Veterans Affairs Medical Center. The Annals of pharmacotherapy, 2023, Volume: 57, Issue:2 Topics: Angiotensin II; Cardiac Surgical Procedures; Humans; Norepinephrine; Retrospective Studies; Shock; Vasoconstrictor Agents; Veterans	2023
Adjunctive vasopressors in distributive shock: How soon is early? Critical care (London, England), 2023, 05-30, Volume: 27, Issue:1 Topics: Angiotensin II; Humans; Hypotension; Shock; Vasoconstrictor Agents	2023
Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis. Critical care medicine, 2023, Dec-01, Volume: 51, Issue:12 Topics: Adult; Angiotensin II; Humans; Multiple Organ Failure; Retrospective Studies; Shock; Vasoconstrictor Agents	2023
A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock. Journal of intensive care medicine, 2020, Volume: 35, Issue:12 Topics: Adult; Angiotensin II; Catecholamines; Humans; Retrospective Studies; Shock; Vasoconstrictor Agents	2020
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Critical care (London, England), 2020, 02-06, Volume: 24, Issue:1 Topics: Angiotensin I; Angiotensin II; Catecholamines; Female; Humans; Male; Shock	2020
Selepressin for Patients With Septic Shock. JAMA, 2020, 02-18, Volume: 323, Issue:7 Topics: Angiotensin II; Humans; Shock; Shock, Septic; Vasoconstrictor Agents; Vasopressins	2020
Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock. Anesthesia and analgesia, 2020, Volume: 131, Issue:1 Topics: Angiotensin II; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Shock; Vasoconstrictor Agents	2020
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series. Critical care (London, England), 2020, May-15, Volume: 24, Issue:1 Topics: Aged; Angiotensin II; Betacoronavirus; Cohort Studies; Coronavirus Infections; COVID-19; Female; Humans; Infusions, Intravenous; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Shock; Vasoconstrictor Agents; Vasodilation	2020
Renin, Angiotensin II, and the Journey to Evidence-based Individual Treatment Effects. American journal of respiratory and critical care medicine, 2020, 11-01, Volume: 202, Issue:9 Topics: Angiotensin II; Catecholamines; Humans; Renin; Renin-Angiotensin System; Shock	2020
Effective Use of Angiotensin II in Coronavirus Disease 19-Associated Mixed Shock State: A Case Report. A&A practice, 2020, Volume: 14, Issue:6 Topics: Aged, 80 and over; Angiotensin II; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Shock; Vasoconstrictor Agents	2020
Vasopressor Therapy in the Intensive Care Unit. Seminars in respiratory and critical care medicine, 2021, Volume: 42, Issue:1 Topics: Angiotensin II; Dopamine; Epinephrine; Humans; Intensive Care Units; Norepinephrine; Shock; Shock, Septic; Vasoconstrictor Agents; Vasopressins	2021
Angiotensin II for Critically Ill Patients With Shock After Heart Transplant. Journal of cardiothoracic and vascular anesthesia, 2021, Volume: 35, Issue:9 Topics: Angiotensin II; Critical Illness; Heart Transplantation; Humans; Prospective Studies; Shock; Vasoplegia	2021
Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use. Chest, 2021, Volume: 159, Issue:2 Topics: Angiotensin II; Female; Hemodynamics; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Retrospective Studies; Shock; United States; Vasoconstrictor Agents	2021
Catecholamine-Sparing Effect of Angiotensin II in an Anephric Patient With Mixed Shock After Cardiac Revascularization Surgery: A Case Report. A&A practice, 2020, Volume: 14, Issue:9 Topics: Angiotensin II; Catecholamines; Humans; Hypotension; Shock; Vasoconstrictor Agents	2020
Angiotensin II Administration in Patients With COVID-19 Shock. Critical pathways in cardiology, 2021, 06-01, Volume: 20, Issue:2 Topics: Aged; Angiotensin II; Arterial Pressure; COVID-19; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock; Vasoconstrictor Agents	2021
In Response. Anesthesia and analgesia, 2020, Volume: 131, Issue:3 Topics: Angiotensin II; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Shock	2020
A Multicenter Observational Cohort Study of Angiotensin II in Shock. Journal of intensive care medicine, 2022, Volume: 37, Issue:1 Topics: Adult; Angiotensin II; Blood Pressure; Humans; Retrospective Studies; Shock; Vasoconstrictor Agents	2022
Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report. A&A practice, 2021, Feb-11, Volume: 15, Issue:2 Topics: Angiotensin II; Humans; Hypotension; Liver Transplantation; Shock; Vasoconstrictor Agents	2021
Angiotensin II for the Treatment of Vasodilatory Shock - Promise and Caution. The New England journal of medicine, 2017, 08-03, Volume: 377, Issue:5 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II in vasodilatory shock: lights and shadows. Critical care (London, England), 2017, 11-14, Volume: 21, Issue:1 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Angiotensin II for the Treatment of Vasodilatory Shock. The New England journal of medicine, 2017, 12-28, Volume: 377, Issue:26 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2017
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. Critical care medicine, 2018, Volume: 46, Issue:6 Topics: Acute Kidney Injury; Aged; Angiotensin II; Humans; Infusions, Intravenous; Middle Aged; Renal Replacement Therapy; Shock; Treatment Outcome	2018
Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe? Critical care (London, England), 2018, 04-16, Volume: 22, Issue:1 Topics: Angiotensin II; Humans; Shock; Vasoconstrictor Agents	2018
Angiotensin in ECMO patients with refractory shock. Critical care (London, England), 2018, Nov-01, Volume: 22, Issue:1 Topics: Adult; Angiotensin II; Angiotensins; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Middle Aged; Shock; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents	2018
Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data. Journal of critical care, 2019, Volume: 50 Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiotensin II; Australia; Canada; Chi-Square Distribution; Europe; Female; Humans; Male; Middle Aged; Neurophysins; Norepinephrine; Prospective Studies; Protein Precursors; Retrospective Studies; Shock; Shock, Septic; United States; Vasoconstrictor Agents; Vasopressins; Young Adult	2019
Blood Pressure Covariance Not Accounted for in Angiotensin II for the Treatment of High-Output Shock 3 Subgroup Analysis. Critical care medicine, 2019, Volume: 47, Issue:3 Topics: Angiotensin II; Blood Pressure; Humans; Patients; Renal Replacement Therapy; Shock	2019
The authors reply. Critical care medicine, 2019, Volume: 47, Issue:3 Topics: Angiotensin II; Humans; Patients; Renal Replacement Therapy; Shock	2019
Novel Considerations in the Management of Shock. Vasopressors, Fluid Responsiveness, and Blood Pressure Targets. American journal of respiratory and critical care medicine, 2019, May-01, Volume: 199, Issue:9 Topics: Angiotensin II; Blood Pressure; Humans; Shock; Vasoconstrictor Agents	2019
Angiotensin II in ECMO patients: a word of caution. Critical care (London, England), 2019, 04-26, Volume: 23, Issue:1 Topics: Angiotensin II; Extracorporeal Membrane Oxygenation; Humans; Retrospective Studies; Shock	2019
Shock pathophysiology. Compendium (Yardley, PA), 2013, Volume: 35, Issue:8 Topics: Angiotensin II; Animals; Blood Circulation; Catecholamines; Hydrocortisone; Shock; Vasopressins	2013
The use of angiotensin II in distributive shock. Critical care (London, England), 2016, May-27, Volume: 20, Issue:1 Topics: Angiotensin II; Humans; Shock	2016
Estradiol potentiates hypothalamic vasopressin and oxytocin neuron activation and hormonal secretion induced by hypovolemic shock. American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 301, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular System; Estradiol; Female; Hypothalamus; Models, Animal; Neurons; Ovariectomy; Oxytocin; Paraventricular Hypothalamic Nucleus; Prolactin; Rats; Rats, Wistar; Shock; Supraoptic Nucleus; Vasopressins	2011
Clinical experience with angiotensin II in the treatment of shock. JAMA, 1961, Dec-09, Volume: 178 Topics: Angiotensin II; Convulsive Therapy; Shock	1961
Canine endotoxin shock: reversal with aldosterone and angiotensin II (hypertensin). Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1962, Volume: 109 Topics: Aldosterone; Angiotensin Amide; Angiotensin II; Animals; Antitoxins; Dogs; Endotoxins; Shock; Toxins, Biological	1962
Influence of aldosterone and angiotensin II on endotoxin shock in the primate. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1963, Volume: 112 Topics: Aldosterone; Angiotensin II; Animals; Endotoxins; Humans; Hypertension; Primates; Shock; Shock, Septic	1963
Angiotensin II in the treatment of shock. The American journal of cardiology, 1963, Volume: 11 Topics: Angiotensin II; Humans; Hypertension; Norepinephrine; Shock	1963
ANGIOTENSIN II IN THE TREATMENT OF SHOCK FOLLOWING MYOCARDIAL INFARCTION. The American journal of cardiology, 1964, Volume: 14 Topics: Angiotensin II; Angiotensins; Blood Pressure; Drug Therapy; Epinephrine; Geriatrics; Humans; Infusions, Parenteral; Mortality; Myocardial Infarction; Shock	1964
[CLINICAL EVALUATION OF ANGIOTENSIN II IN THE INITIAL PHASE OF SHOCK]. Medicina, 1964, Sep-10, Volume: 44 Topics: Angiotensin II; Angiotensins; Child; Drug Therapy; Geriatrics; Hypotension; Shock	1964
[EXPERIMENTAL AND CLINICAL TESTS WITH BETA-ANGIOTENSIN II (PREPARATION CIBA 33 902-BA), A NEW ANGIOTENSIN II-ANALOGUE WITH INCREASED AND PROLONGED PRESSOR EFFECT]. Schweizerische medizinische Wochenschrift, 1964, Aug-29, Volume: 94 Topics: Angiotensin II; Angiotensins; Drug Therapy; Humans; Hypotension; Shock; Shock, Hemorrhagic; Shock, Traumatic; Vasoconstrictor Agents	1964
Heat shock treatment suppresses angiotensin II-induced activation of NF-kappaB pathway and heart inflammation: a role for IKK depletion by heat shock? American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Heat-Shock Proteins; Hot Temperature; HSP70 Heat-Shock Proteins; I-kappa B Kinase; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Myocarditis; Myocardium; NF-kappa B; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Shock	2004
CNS pathways mediating cardiovascular regulation of vasopressin. Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:2 Topics: Angiotensin II; Blood Pressure; Cardiovascular Physiological Phenomena; Hypotension; Hypothalamus; Neurosecretory Systems; Pressoreceptors; Shock; Subfornical Organ; Vasopressins	1996
Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock (Augusta, Ga.), 1997, Volume: 8, Issue:5 Topics: Angiotensin II; Animals; Bicarbonates; Duodenum; Enalaprilat; Guanethidine; Hemodynamics; Intestinal Mucosa; Membrane Potentials; Multiple Organ Failure; Norepinephrine; Renin-Angiotensin System; Shock; Splanchnic Circulation; Swine; Sympathetic Nervous System; Sympatholytics	1997
Vascular expression of heat shock protein 72 in fructose-induced hypertensive rats. The Chinese journal of physiology, 1998, Volume: 41, Issue:1 Topics: Angiotensin II; Animals; Aorta; Cells, Cultured; Fructose; Heat-Shock Proteins; Hot Temperature; HSP72 Heat-Shock Proteins; Hypertension; Male; Muscle, Smooth, Vascular; Norepinephrine; Rats; Rats, Sprague-Dawley; Shock	1998
[Refractory shock after converting enzyme inhibitor administration. Usefulness of angiotensin II]. Presse medicale (Paris, France : 1983), 2000, Apr-08, Volume: 29, Issue:13 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Fluid Therapy; Humans; Lisinopril; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance; Vasoconstrictor Agents	2000
The effect of chronic cocaine administration on hemodynamic stability and neurohumoral mediators during isoflurane anesthesia and shock in rats. Acta anaesthesiologica Scandinavica, 2001, Volume: 45, Issue:3 Topics: Anesthesia; Anesthetics, Inhalation; Angiotensin II; Animals; Arginine Vasopressin; Cocaine; Epinephrine; Hemodynamics; Isoflurane; Male; Norepinephrine; Rats; Shock; Vasoconstrictor Agents	2001
The pathophysiology of shock. British journal of hospital medicine, 1979, Volume: 22, Issue:5 Topics: Angiotensin II; Blood Circulation; Blood Viscosity; Body Fluids; Catecholamines; Heart; Hematocrit; Histamine; Humans; Hydrogen-Ion Concentration; Kidney; Kinins; Liver; Lung; Oxygen Consumption; Oxyhemoglobins; Prostaglandins; Respiration; Shock; Shock, Cardiogenic; Vasoconstriction; Vasodilation	1979
Plasma renin and angiotensin II in acute renal failure. Lancet (London, England), 1977, Aug-13, Volume: 2, Issue:8033 Topics: Acute Kidney Injury; Angiotensin II; Blood Pressure; Creatinine; Humans; Hypotension, Controlled; Kidney; Kidney Function Tests; Oliguria; Osmolar Concentration; Renin; Shock; Surgical Procedures, Operative	1977
Shock and the kidney: pathophysiology and pharmacological support. Intensive care medicine, 1977, Volume: 3, Issue:1 Topics: Acute Kidney Injury; Adrenocorticotropic Hormone; Angiotensin II; Catecholamines; Diuretics; Glomerular Filtration Rate; Hemodynamics; Humans; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Renal Dialysis; Shock; Vasodilator Agents	1977
Renal blood flow in various types of hypotension and shock in dogs and men (preliminary report). Medical journal of Osaka University, 1978, Volume: 29, Issue:3-4 Topics: Angiotensin II; Animals; Catecholamines; Dogs; Hemodynamics; Humans; Hypotension, Controlled; Kidney; Regional Blood Flow; Renin; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic	1978
[Circulatory regulation during hypovolemic shock]. Ugeskrift for laeger, 1986, Sep-15, Volume: 148, Issue:38 Topics: Adult; Aged; Aldosterone; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pancreatic Polypeptide; Posture; Shock; Vasopressins	1986
Angiotensin II restoration of reflex adrenal medullary secretion to anephric dogs is physiologically dose dependent. Endocrinology, 1985, Volume: 117, Issue:5 Topics: Adrenal Glands; Adrenal Medulla; Angiotensin II; Animals; Catecholamines; Dogs; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Kidney; Nephrectomy; Norepinephrine; Reflex; Secretory Rate; Shock	1985
Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran. Archives of internal medicine, 1965, Volume: 116, Issue:4 Topics: Adult; Aged; Angiotensin II; Cardiac Output; Dextrans; Hemodynamics; Humans; Hypotension; Metaraminol; Middle Aged; Norepinephrine; Shock; Vascular Resistance; Vasoconstrictor Agents	1965
The role of angiotensinase activity in the diminished pressor response to angiotensin. Acta medica Academiae Scientiarum Hungaricae, 1965, Volume: 21, Issue:2 Topics: Angiotensin II; Animals; Blood; Blood Pressure; Dogs; Endopeptidases; In Vitro Techniques; Peptide Hydrolases; Shock; Tachyphylaxis	1965
[First clinical experiences on the use of beta-angiotensin II. Treatment of a grave case of shock]. Gazzetta internazionale di medicina e chirurgia, 1965, Sep-30, Volume: 69, Issue:18 Topics: Adult; Anaphylaxis; Angiotensin II; Female; Humans; Obstetric Labor Complications; Pregnancy; Shock	1965
Mechanisms of pressor amine dependence. The American journal of cardiology, 1965, Volume: 16, Issue:6 Topics: Adult; Aged; Angiotensin II; Blood Circulation; Blood Volume; Cardiac Output; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Kidney Function Tests; Male; Metaraminol; Middle Aged; Norepinephrine; Shock; Water-Electrolyte Balance	1965
[Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock]. Bibliotheca cardiologica, 1966, Volume: 17 Topics: Angiotensin II; Animals; Coronary Disease; Dogs; Electrocardiography; Epinephrine; Heart; Heart Rate; Humans; Isoproterenol; Mephentermine; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance	1966
Relation of cardiac work to survival in cardiogenic shock in dogs. JAMA, 1967, Mar-13, Volume: 199, Issue:11 Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Dextrans; Dogs; Electricity; Hemodynamics; Isoproterenol; Norepinephrine; Phenoxybenzamine; Shock; Transducers; Vascular Resistance	1967
[Clinical studies of the effectiveness of hypertensin under conditions of anesthesia and shock]. Das Deutsche Gesundheitswesen, 1966, Feb-24, Volume: 21, Issue:8 Topics: Adult; Aged; Anesthesia; Angiotensin II; Female; Humans; Male; Middle Aged; Shock	1966
Influence of vasoexcitor-pressor drugs on microvascular injury in shock. Bibliotheca anatomica, 1967, Volume: 9 Topics: Angiotensin II; Animals; Appendix; Blood Vessels; Mesentery; Norepinephrine; Rats; Shock; Shock, Hemorrhagic; Shock, Traumatic; Vasoconstrictor Agents; Vasomotor System	1967
[Influence of angiotensin on cardiac output in shock]. Comptes rendus des seances de la Societe de biologie et de ses filiales, 1966, Volume: 160, Issue:12 Topics: Angiotensin II; Animals; Cardiac Output; Dogs; Shock	1966
Electrocardiographic moniteering of patients of shock on angiotensin and noradrenaline therapy. The Journal of the Association of Physicians of India, 1967, Volume: 15, Issue:4 Topics: Adolescent; Adult; Angiotensin II; Electrocardiography; Female; Humans; Male; Middle Aged; Norepinephrine; Shock	1967
Microphysiology of vasopressors in shock. Vascular surgery, 1967, Volume: 1, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Metaraminol; Methoxamine; Motion Pictures; Norepinephrine; Photomicrography; Rabbits; Regional Blood Flow; Shock; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System	1967
Influence of positive inotropic agents on the action of a myocardial depressant factor in the plasma of cats in postoligemic shock. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1967, Volume: 126, Issue:2 Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Blood Volume; Cardiac Glycosides; Cats; Female; Male; Muscle Contraction; Norepinephrine; Ouabain; Shock; Sympathomimetics	1967
[Shock therapy with vasodilator and-or vasoconstrictor agents]. Helvetica chirurgica acta, 1967, Volume: 34, Issue:1 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Diuresis; Female; Humans; Isoproterenol; Norepinephrine; Sepsis; Shock; Vascular Diseases; Vasoconstrictor Agents; Vasodilator Agents	1967
[The treatment of shock with isoproterenol]. Schweizerische medizinische Wochenschrift, 1966, May-07, Volume: 96, Issue:18 Topics: Adult; Aged; Angiotensin II; Blood Circulation; Female; Humans; Isoproterenol; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Pulmonary Embolism; Shock; Shock, Hemorrhagic; Shock, Septic	1966
[Absence of favorable effects of pressor agents on cardiac output and peripheral circulatory flow in advanced shock]. Pathologie et biologie, 1968, Volume: 16, Issue:1 Topics: Angiotensin II; Animals; Cardiac Output; Dogs; Epinephrine; Female; Male; Norepinephrine; Shock	1968
[Inzellen--hypertensin in the treatment of severe shock]. Die Medizinische Welt, 1968, Feb-03, Volume: 5 Topics: Adult; Angiotensin II; Asparagine; Female; Humans; Infusions, Parenteral; Magnesium; Potassium; Shock	1968
[Results of treatment of myocardial infarction associated with shock in relation to the kind of administered drugs]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1968, May-06, Volume: 23, Issue:19 Topics: Adult; Aged; Angiotensin II; Epinephrine; Female; Humans; Hydrocortisone; Male; Middle Aged; Morphine; Myocardial Infarction; Shock; Strophanthins	1968
Microvascular effects of vasoactive agents in shock. The British journal of surgery, 1968, Volume: 55, Issue:10 Topics: Aged; Angiotensin II; Animals; Arteries; Blood; Blood Vessels; Cheek; Cricetinae; Epinephrine; Female; Humans; Norepinephrine; Phenoxybenzamine; Phentolamine; Plasma; Shock; Vasoconstrictor Agents; Veins	1968
Sustained complete autonomic blockade. British journal of pharmacology, 1969, Volume: 35, Issue:2 Topics: Angiotensin II; Animals; Atropine; Autonomic Nerve Block; Blood Pressure; Cardiac Output; Dogs; Dopamine; Epinephrine; Ganglia, Autonomic; Sheep; Shock; Time Factors; Trimethaphan	1969
Results of treatment of myocardial infarction accompanied by shock in relation to drugs applied. Polish medical journal, 1969, Volume: 8, Issue:2 Topics: Adult; Aged; Angiotensin II; Female; Humans; Hydrocortisone; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Shock	1969
[Incidence of cardiogenic shock in patients with acute myocardial infarct. A few remarks on mortality and therapeutic possibilities]. Casopis lekaru ceskych, 1969, May-23, Volume: 108, Issue:22 Topics: Angiotensin II; Cardiac Output; Female; Humans; Injections, Intravenous; Male; Myocardial Infarction; Norepinephrine; Shock	1969
Hemodynamic spectrum of vasopressor and vasodilator drugs. JAMA, 1969, May-26, Volume: 208, Issue:8 Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Epinephrine; Heart Rate; Hemodynamics; Isoproterenol; Metaraminol; Methoxamine; Norepinephrine; Phenoxybenzamine; Phentolamine; Phenylephrine; Shock; Sympatholytics; Vasoconstrictor Agents; Vasodilator Agents	1969
[Importance of regional circulation for treatment of cardiogenic shock]. Arzneimittel-Forschung, 1969, Volume: 19, Issue:5 Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Cardiac Output; Dogs; Epinephrine; Heart Rate; Hemodynamics; Humans; Lactates; Metaproterenol; Myocardial Infarction; Oxygen Consumption; Pyruvates; Regional Blood Flow; Shock; Vascular Resistance; Veins	1969
[Our clinical experience with a new hypertensive drug: beta-L-angiotensin II (Ciba 33'902 BA)]. Minerva cardioangiologica, 1968, Volume: 16, Issue:2 Topics: Adolescent; Adult; Angiotensin II; Burns; Female; Humans; Intestinal Obstruction; Male; Middle Aged; Shock; Shock, Traumatic; Wounds and Injuries	1968
[Treatment of hypotension in anesthesiological practice. Indications and limitations of modern hypotensive drugs]. Minerva anestesiologica, 1969, Volume: 35, Issue:11 Topics: Anesthesia; Angiotensin II; Epinephrine; Humans; Hypotension; Norepinephrine; Octopamine; Shock; Synephrine	1969
Studies in clinical shock and hypotension. VII. Renal hemodynamics before and during treatment. Circulation, 1970, Volume: 42, Issue:5 Topics: Acetylcholine; Adult; Aged; Angiotensin II; Blood Flow Velocity; Blood Urea Nitrogen; Cardiac Output; Dextrans; Dopamine; Dye Dilution Technique; Humans; Hydralazine; Hypotension; Isoproterenol; Kidney; Male; Metaraminol; Middle Aged; Norepinephrine; Plasma Substitutes; Regional Blood Flow; Shock; Vascular Resistance; Vasoconstrictor Agents	1970
[Risks of secondary circulatory failure at the time of excessive perfusion with vasoconstrictor agents]. European journal of toxicology, 1970, Volume: 3, Issue:3 Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Carbon Dioxide; Dogs; Epinephrine; Female; Hydrocortisone; Hypotension; Infusions, Parenteral; Lactates; Male; Oxygen Consumption; Phentolamine; Shock; Vasoconstrictor Agents	1970
Radio-fibrinogen studies in renal hypertension. Angiologica, 1971, Volume: 8, Issue:2 Topics: Acidosis; Anemia, Hemolytic; Angiotensin II; Animals; Aorta; Desoxycorticosterone; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemolysis; Hypertension; Hypertension, Renal; Hypoxia; Ligation; Methoxamine; Nephrectomy; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Progesterone; Rabbits; Rats; Renal Artery; Serum Albumin, Radio-Iodinated; Shock; Uremia	1971
Shock in acute pancreatitis and hypovolaemia. Gut, 1972, Volume: 13, Issue:10 Topics: Acute Disease; Angiotensin II; Animals; Blood Volume; Dogs; Hypotension; Macroglobulins; Pancreatitis; Shock; Trypsin	1972
[Therapy of shock using vaso- and coagulation-active substances. Behavior of tissue oxygen in the dog kidney under the influence of vaso- and coagulation-active substances]. Fortschritte der Medizin, 1972, Nov-16, Volume: 90, Issue:32 Topics: Angiotensin II; Animals; Dogs; Kidney; Norepinephrine; Oxygen Consumption; Shock; Streptokinase; Thrombin; Vasoconstrictor Agents	1972
[Letter: Hypertensin]. Deutsche medizinische Wochenschrift (1946), 1973, Nov-02, Volume: 98, Issue:44 Topics: Angiotensin II; Blood Pressure; Coronary Vessels; Heart; Kidney; Norepinephrine; Oxygen Consumption; Shock	1973
Pharmacology of pressor agents on the systemic circulation. Seminars in drug treatment, 1973,Winter, Volume: 3, Issue:3 Topics: Action Potentials; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Epinephrine; Humans; Isoproterenol; Mephentermine; Metaraminol; Methoxamine; Norepinephrine; Phenylephrine; Pituitary Hormones, Posterior; Receptors, Adrenergic; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Vasoconstrictor Agents	1973
The pathogenesis of anuria following shock. Kidney international, 1974, Volume: 5, Issue:2 Topics: Acute Kidney Injury; Aminohippuric Acids; Angiotensin II; Animals; Anuria; Blood Pressure; Chromium Radioisotopes; Edetic Acid; Glomerular Filtration Rate; Humans; Indicator Dilution Techniques; Indocyanine Green; Inulin; Kidney; Kidney Function Tests; Norepinephrine; Prostaglandins; Radioisotopes; Regional Blood Flow; Renin; Shock; Sodium Isotopes	1974
Reticuloendothelial function in experimental injury and tolerance to shock. Advances in experimental medicine and biology, 1972, Volume: 33, Issue:0 Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Catheterization; Female; Intestine, Large; Ischemia; Mononuclear Phagocyte System; Norepinephrine; Phagocytes; Phagocytosis; Rats; Shock; Shock, Hemorrhagic; Shock, Traumatic; Vasopressins	1972
[On the regulation of kidney blood circulation. Animal experiment studies by means of renal vein catheterization]. Archiv fur Kreislaufforschung, 1966, Volume: 49, Issue:3 Topics: Acetylcholine; Angiotensin II; Animals; Atropine; Blood Circulation; Blood Pressure; Carbon Dioxide; Cardiac Catheterization; Catheterization; Chloralose; Dogs; Electrocardiography; Ergotamine; Ethanolamines; Ethyl Ethers; Femoral Artery; Femoral Vein; Halothane; Isoproterenol; Kidney; Nitroglycerin; Norepinephrine; Nucleosides; Shock; Urethane; Vasoconstrictor Agents; Vasodilator Agents	1966